Predicting atrial fibrillation in pacemaker patients
Part of Heart & circulation clinical trials.
This study is looking at whether two blood tests (hs Troponin I and NT-proBNP) can help predict if people with a permanent pacemaker will develop atrial fibrillation, a common heart rhythm problem. If you need a pacemaker, you may be able to join and help researchers learn more.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You need a permanent pacemaker and agree to have one placed.
- You should not have had atrial fibrillation in the past or have it now.
- You must not be very ill, at risk of death, or have a serious infection.
- Your kidney function must be above a certain level (eGFR above 30).
- You cannot be pregnant or scheduled for surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a database to better predict who with a pacemaker or ICD will develop atrial fibrillation (an irregular heart rhythm). It may help your care team spot risk earlier and tailor monitoring sooner.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This study looks for patterns that can predict an abnormal heart rhythm called SCAF in people who have a pacemaker or defibrillator. The goal is to help doctors recognize risk earlier and respond sooner if it happens.
This study looks at how a dual-chamber pacemaker affects the risk of developing atrial fibrillation. It may help people who need a pacemaker understand their long-term heart health.
This trial studies whether a strategy to regularize (control) heart rate can improve outcomes in people who have permanent atrial fibrillation and heart failure. It focuses on people with recent heart-failure hospitalization and checks several heart, kidney, and health-condition limits to keep the study safe.
This trial tests a new type of pacemaker for people with atrial fibrillation who are scheduled for a procedure that disconnects the heart's natural electrical pathway. It may help improve symptoms and heart function.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.